Active Oxygen and Negative Ion Sanitary Pads for Episiotomy Pain, Healing, and Postpartum Symptoms
Effects of Active Oxygen and Negative Ion Sanitary Pads on Episiotomy Pain, Healing, and Postpartum Physical Symptom Severity in Primiparous Women: A Randomized Controlled Trial
1 other identifier
interventional
66
1 country
1
Brief Summary
This study is to assess the impact of sanitary pads infused with active oxygen and negative ions on episiotomy pain, wound healing, and postpartum physical symptoms in primiparous women. Participants will be randomly allocated to either the intervention group, utilizing active oxygen and negative ion pads, or the control group, employing normal postpartum pads. The research will assess pain intensity, recovery advancement, and physical manifestations during the initial postpartum phase. The objective is to ascertain if the intervention offers supplementary advantages relative to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
March 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 9, 2026
CompletedMay 12, 2026
December 1, 2025
5 months
December 3, 2025
May 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Episiotomy Pain Score
Episiotomy-related pain will be assessed using a 10-point Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.
Measurements will be conducted at: • 24 hours postpartum • 3rd day postpartum • 7th day postpartum
Episiotomy Wound Healing Score
Wound healing will be evaluated using the REEDA Scale (Redness, Edema, Ecchymosis, Discharge, Approximation). Each item is scored from 0 to 3, with a total score ranging from 0 to 15. Higher scores indicate poorer wound healing (greater tissue trauma).
Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum
Postpartum Physical Symptom Severity
Postpartum physical symptom severity will be measured using the Postpartum Physical Symptom Severity Scale. The scale consists of 18 items, each rated on a 4-point Likert scale (0 = none, 1 = mild, 2 = moderate, 3 = severe), with total scores ranging from 0 to 54. Higher scores indicate greater severity of postpartum physical symptoms.
Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum
Study Arms (2)
Pad Group
EXPERIMENTALParticipants in this group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy. All participants will also receive routine postpartum care.
Control Group
ACTIVE COMPARATORParticipants in this group will use standard postpartum sanitary pads during the early postpartum period following episiotomy. All participants will also receive routine postpartum care.
Interventions
Participants in the intervention group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy. The product is applied as a hygiene pad and is not classified as a drug or medical device. Routine postpartum care will be provided to all participants.
Participants in the control group will use standard postpartum sanitary pads following episiotomy. Routine postpartum care will be provided to all participants. The control product does not contain active oxygen or negative ions.
Eligibility Criteria
You may qualify if:
- Women aged 18 years or older
- At least primary school education
- Gestational age between 37 and 42 weeks
- Single, live, vaginal birth
- Mediolateral episiotomy performed
- Hemoglobin level \> 11 mg/dL
- Voluntary participation and ability to provide informed consent
You may not qualify if:
- History of high-risk pregnancy
- History of high-risk or complicated labor
- Use of operative vaginal delivery methods (forceps, vacuum, etc.)
- Presence of additional perineal lacerations, including 3rd-degree tears or anal sphincter injury
- Cephalopelvic disproportion
- Postpartum hemorrhage
- Newborn requiring NICU care
- Diagnosis of vaginal fungal infection or sexually transmitted infections (e.g., herpes simplex, HPV)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eğitim ve Araştırma Hastanesi
Karaman, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The statistician conducting data analysis will be blinded to group assignments. Participants, care providers, and investigators will not be blinded due to the nature of the intervention.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2025
First Posted
March 23, 2026
Study Start
November 1, 2025
Primary Completion
April 1, 2026
Study Completion
May 9, 2026
Last Updated
May 12, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to ethical restrictions, privacy protection regulations, and institutional policies. Only aggregated study results will be reported